FIELD: medicine.
SUBSTANCE: present group of inventions relates to medicine, namely to therapy, and concerns treating atherosclerosis and hypertriglyceridemia. For that compound of formula 
or formula 
is introduced in effective amount.
EFFECT: it provides treatment, reduction of intensity and/or prevention of such diseases and pathological conditions, as atherosclerosis and dyslipidemia, in individual with high levels of triglycerides.
12 cl, 2 tbl, 58 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INDOLE DERIVATIVES CONTAINING ACETYLENE GROUP AS PPAR ACTIVATORS | 2005 |
|
RU2387639C2 |
| APPLICATION OF SUBSTITUTED CYANOPYROLIDINES AND COMBINED PREPARATIONS CONTAINING THEM FOR TREATMENT OF LIPIDEMIA AND ASSOCIATED DISEASES | 2003 |
|
RU2362555C2 |
| BICYCLIC DERIVATIVES AS CEPT INHIBITORS | 2007 |
|
RU2430917C2 |
| ISOXAZOLO-PYRIDINE DERIVATIVES | 2008 |
|
RU2484091C2 |
| AZOLE DERIVATIVES AS LIPASE AND PHOSPHOLIPASE INHBITORS | 2006 |
|
RU2414458C2 |
| INTRODUCTION OF ANTISENSE OLIGINUCLEOTIDES, COMPLEMENTARY TO HUMAN APOLYPOPROTEIN B | 2008 |
|
RU2559536C2 |
| USE OF THIA OXO COMPOUNDS FOR LOWERING APO C3 CONTENT | 2015 |
|
RU2705991C2 |
| NEW PYRROLO[3,2-d]PYRIMIDIN-4-ONE DERIVATIVES AND USING THEM IN THERAPY | 2005 |
|
RU2577858C2 |
| 5-(3,4-DICHLOROPHENYL)-N-(2-HYDROXYCYCLOHEXYL)-6-(2,2,2-TRIFLUOROETHOXY)NICOTINAMIDE AND ITS SALT AS AGENTS INCREASING HIGH-DENSITY LIPOPROTEIN CHOLESTEROL CONCENTRATION | 2010 |
|
RU2541475C2 |
| NEUROACTIVE COMPOUNDS AND THEIR APPLICATION METHODS | 2015 |
|
RU2764702C2 |
